1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NBPF15 CTRPv2 pan-cancer AAC -0.2 2e-08
mRNA EMC6 CTRPv2 pan-cancer AAC -0.19 6e-08
mRNA SCAMP3 CTRPv2 pan-cancer AAC -0.19 1e-07
mRNA GPATCH4 CTRPv2 pan-cancer AAC -0.19 1e-07
mRNA UTP3 CTRPv2 pan-cancer AAC -0.19 5e-07
mRNA POU2AF1 CTRPv2 pan-cancer AAC -0.18 7e-06
mRNA DEF8 CTRPv2 pan-cancer AAC -0.18 2e-07
mRNA KIF1C CTRPv2 pan-cancer AAC -0.18 9e-06
mRNA RAB13 CTRPv2 pan-cancer AAC -0.18 2e-05
mRNA MRPS18B CTRPv2 pan-cancer AAC -0.17 6e-07
Download CSV